DK0869970T3 - Endothelcelleprolifereringsinhibitor og dens anvendelse - Google Patents

Endothelcelleprolifereringsinhibitor og dens anvendelse

Info

Publication number
DK0869970T3
DK0869970T3 DK96945635T DK96945635T DK0869970T3 DK 0869970 T3 DK0869970 T3 DK 0869970T3 DK 96945635 T DK96945635 T DK 96945635T DK 96945635 T DK96945635 T DK 96945635T DK 0869970 T3 DK0869970 T3 DK 0869970T3
Authority
DK
Denmark
Prior art keywords
cell proliferation
endothelial cell
proliferation inhibitor
inhibitor
endothelial
Prior art date
Application number
DK96945635T
Other languages
Danish (da)
English (en)
Inventor
Donald J Davidson
Yihai Cao
Moses Judah Folkman
Michael S O'reilly
Original Assignee
Abbott Lab
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/763,528 external-priority patent/US5854221A/en
Application filed by Abbott Lab, Childrens Medical Center filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0869970T3 publication Critical patent/DK0869970T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6435Plasmin (3.4.21.7), i.e. fibrinolysin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21007Plasmin (3.4.21.7), i.e. fibrinolysin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Farming Of Fish And Shellfish (AREA)
DK96945635T 1995-12-13 1996-12-13 Endothelcelleprolifereringsinhibitor og dens anvendelse DK0869970T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US851995P 1995-12-13 1995-12-13
US08/763,528 US5854221A (en) 1996-12-12 1996-12-12 Endothelial cell proliferation inhibitor and method of use

Publications (1)

Publication Number Publication Date
DK0869970T3 true DK0869970T3 (da) 2004-07-05

Family

ID=26678280

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96945635T DK0869970T3 (da) 1995-12-13 1996-12-13 Endothelcelleprolifereringsinhibitor og dens anvendelse

Country Status (20)

Country Link
US (1) US20010016644A1 (ja)
EP (1) EP0869970B1 (ja)
JP (1) JP3684371B2 (ja)
KR (1) KR100477280B1 (ja)
CN (1) CN1554444A (ja)
AT (1) ATE262537T1 (ja)
AU (1) AU710612B2 (ja)
BR (1) BR9612115A (ja)
CA (1) CA2240296C (ja)
CZ (1) CZ298612B6 (ja)
DE (1) DE69631972T2 (ja)
DK (1) DK0869970T3 (ja)
ES (1) ES2217340T3 (ja)
HK (1) HK1017692A1 (ja)
HU (1) HUP9900979A3 (ja)
NO (1) NO321775B1 (ja)
NZ (1) NZ330537A (ja)
PL (1) PL188719B1 (ja)
PT (1) PT869970E (ja)
WO (1) WO1997023500A1 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9900979A3 (en) * 1995-12-13 2001-10-29 Children S Medical Ct Corp Bos Endothelial cell proliferation inhibitor and method of use
JP4426650B2 (ja) * 1996-05-03 2010-03-03 アボット・ラボラトリーズ 新規な抗血管形成ペプチド、それをコードするポリヌクレオチド、および血管形成を阻害する方法
US5801146A (en) * 1996-05-03 1998-09-01 Abbott Laboratories Compound and method for inhibiting angiogenesis
US6699838B1 (en) 1996-05-03 2004-03-02 Abbott Laboratories Antiangiogenic peptides
US5801012A (en) 1996-09-17 1998-09-01 Northwestern University Methods and compositions for generating angiostatin
JP2002510209A (ja) * 1997-06-26 2002-04-02 カロリンスカ イノベイションズ アクチボラゲット インビボで血管形成を調節することができるプラスミノーゲンのクリングルドメイン1−5
AU1598599A (en) * 1997-11-20 1999-06-15 Genetix Pharmaceuticals, Inc. Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases
US6632961B1 (en) 1998-05-22 2003-10-14 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
US7144854B1 (en) 1999-09-10 2006-12-05 Conjuchem, Inc. Long lasting anti-angiogenic peptides
EA003922B1 (ru) 1999-05-17 2003-10-30 Конджачем, Инк. Продолжительно действующие инсулинотропные пептиды
AU764103B2 (en) * 1999-05-17 2003-08-07 Conjuchem Biotechnologies Inc. Long lasting anti-angiogenic peptides
AU784359B2 (en) * 1999-12-15 2006-03-16 Entremed, Inc Compositions and methods for inhibiting endothelial cell proliferation
AU8591901A (en) 2000-09-05 2002-03-22 Karolinska Innovations Ab Materials and methods relating to endothelial cell growth inhibitors
AU2002239414A1 (en) * 2000-11-02 2002-05-27 Bristol-Myers Squibb Company Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors
EP2444805A3 (en) * 2004-01-21 2012-06-20 Fujirebio America, Inc. Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity
CN100355458C (zh) * 2005-03-16 2007-12-19 北京大学 人增殖抑制基因-腺病毒表达载体的应用
WO2010138631A1 (en) 2009-05-26 2010-12-02 Biolex Therapeutics, Inc. Compositions and methods for production of aglycosylated plasminogen
CN103060265B (zh) * 2013-01-23 2014-12-03 山东大学 老年大鼠脑血管内皮细胞原代培养方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
US5302390A (en) * 1987-07-01 1994-04-12 Beecham Group Plc Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment
CA2101614A1 (en) * 1992-07-30 1994-01-31 Shmuel Shaltiel Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them
NZ285501A (en) * 1994-04-26 1998-02-26 Childrens Medical Center Plasminogen analogs (angiostatin), endothelial inhibitors, assays and kits
EP0758393A1 (en) * 1994-04-26 1997-02-19 PHARMACIA & UPJOHN COMPANY Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils
NZ307044A (en) * 1995-04-26 2002-03-01 Childrens Medical Center Angiostatin fragments with antiangiogenic activity
HUP9900979A3 (en) * 1995-12-13 2001-10-29 Children S Medical Ct Corp Bos Endothelial cell proliferation inhibitor and method of use

Also Published As

Publication number Publication date
NZ330537A (en) 2001-06-29
JP2002502359A (ja) 2002-01-22
HUP9900979A3 (en) 2001-10-29
JP3684371B2 (ja) 2005-08-17
ES2217340T3 (es) 2004-11-01
DE69631972D1 (de) 2004-04-29
EP0869970A1 (en) 1998-10-14
ATE262537T1 (de) 2004-04-15
CZ298612B6 (cs) 2007-11-21
CA2240296C (en) 2004-05-04
NO982715D0 (no) 1998-06-12
CZ182898A3 (cs) 1998-10-14
PL327200A1 (en) 1998-11-23
AU710612B2 (en) 1999-09-23
WO1997023500A1 (en) 1997-07-03
HUP9900979A2 (hu) 1999-07-28
US20010016644A1 (en) 2001-08-23
CA2240296A1 (en) 1997-07-03
KR100477280B1 (ko) 2005-07-18
KR19990072126A (ko) 1999-09-27
EP0869970B1 (en) 2004-03-24
NO982715L (no) 1998-08-12
HK1017692A1 (en) 1999-11-26
EP0869970A4 (en) 2002-01-30
DE69631972T2 (de) 2005-01-05
AU1687097A (en) 1997-07-17
BR9612115A (pt) 1999-02-17
PT869970E (pt) 2004-08-31
PL188719B1 (pl) 2005-04-29
NO321775B1 (no) 2006-07-03
CN1554444A (zh) 2004-12-15

Similar Documents

Publication Publication Date Title
DK0869970T3 (da) Endothelcelleprolifereringsinhibitor og dens anvendelse
ATE183196T1 (de) Peptidinhibitoren von fibronectin und verwandten kollagen-bindenden proteinen
DE69433168D1 (de) In vitro vermehrung von stammzellen
FI962350A (fi) BPM-12, BMP-13 sekä niiden jännettä indusoivat koostumukset
ATE172743T1 (de) Nachweis von kollagenabbau -i(in vivo)
ATE281469T1 (de) Inhibitor des wachstumsfaktors für gefäss- endothelzellen
BR9707049A (pt) Agentes anticoagulantes utilizáveis no tratamento de trombose
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
ATE400289T1 (de) Verwendung vom vaskulären endothelialen wachstumsfaktor 2 (vegf-2)
NO960939L (no) Kininogenaseinhibitor
DK0830130T3 (da) TNF-alfa-omdannende enzym
DE59410132D1 (de) Humanes zirkulierendes cytokin cc-1
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
BR9407357A (pt) Novos tripeptideos utilizáveis em terapia cns e imune
FR2676059B1 (fr) Nouveaux derives de peptides utilisables comme inhibiteurs de collagenases bacteriennes.
ATE310083T1 (de) Deprenyl induziertes protein
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
DE69530779D1 (de) Muramylpeptide zusammensetzungen für inhibierung von hiv replikation
MY106261A (en) Anti-inflammatory 1-heteroaryl oxindole-3-carboxamides.
RU95114125A (ru) Ингибитор пролиферации стволовых кроветворных клеток